17652946|t|Detection of active fraction of glycogen synthase kinase 3beta in cancer cells by nonradioisotopic in vitro kinase assay.
17652946|a|Glycogen synthase kinase 3beta (GSK3beta) is a well-known marker and potential therapeutic target in non-insulin-dependent diabetes mellitus and Alzheimer's disease. Our recent demonstration that GSK3beta has a previously unrecognized role in colorectal cancer facilitates the development of a nonradioisotopic in vitro kinase assay (NRIKA) for detecting GSK3beta activity in gastrointestinal cancer cells. The NRIKA uses a sequential combination of immunoprecipitations to isolate GSK3beta in sample cells' lysates, and an in vitro kinase reaction that uses recombinant beta-catenin protein (substrate) and nonradioisotopic ATP, followed by immunoblotting to detect beta-catenin phosphorylated in serine 33, 37 and/or threonine 41 residues. The NRIKA detected higher expression of active GSK3beta in stomach, colon, pancreas and liver cancer cell lines than in human embryonic kidney cells (HEK293) considered nonneoplastic. Inhibition of cancer cell-derived GSK3beta activity by GSK3beta inhibitors (SB-216763, AR-A014418) was detected by the NRIKA. GSK3beta inhibition attenuated survival and proliferation and induced apoptosis in all types of cancer cells but not in HEK293. These findings supported the idea that the pathologic roles of GSK3beta are definite and common in various types of cancer. The NRIKA provides a basis for evolving a high-throughput tool for testing substances for GSK3beta inhibition, and for screening and identifying novel GSK3beta inhibitors with a view to discovering drugs for treatment of cancer as well as non-insulin-dependent diabetes mellitus and Alzheimer's disease.
17652946	32	62	glycogen synthase kinase 3beta	Gene	2932
17652946	66	72	cancer	Disease	MESH:D009369
17652946	122	152	Glycogen synthase kinase 3beta	Gene	2932
17652946	154	162	GSK3beta	Gene	2932
17652946	223	262	non-insulin-dependent diabetes mellitus	Disease	MESH:D003924
17652946	267	286	Alzheimer's disease	Disease	MESH:D000544
17652946	318	326	GSK3beta	Gene	2932
17652946	365	382	colorectal cancer	Disease	MESH:D015179
17652946	477	485	GSK3beta	Gene	2932
17652946	498	521	gastrointestinal cancer	Disease	MESH:D005770
17652946	604	612	GSK3beta	Gene	2932
17652946	693	705	beta-catenin	Gene	1499
17652946	747	750	ATP	Chemical	MESH:D000255
17652946	789	801	beta-catenin	Gene	1499
17652946	911	919	GSK3beta	Gene	2932
17652946	923	930	stomach	Disease	MESH:D013272
17652946	932	964	colon, pancreas and liver cancer	Disease	MESH:D015179
17652946	984	989	human	Species	9606
17652946	1014	1020	HEK293	CellLine	CVCL:0045
17652946	1062	1068	cancer	Disease	MESH:D009369
17652946	1082	1090	GSK3beta	Gene	2932
17652946	1103	1111	GSK3beta	Gene	2932
17652946	1124	1133	SB-216763	Chemical	MESH:C417521
17652946	1135	1145	AR-A014418	Chemical	MESH:C479831
17652946	1174	1182	GSK3beta	Gene	2932
17652946	1270	1276	cancer	Disease	MESH:D009369
17652946	1294	1300	HEK293	CellLine	CVCL:0045
17652946	1365	1373	GSK3beta	Gene	2932
17652946	1418	1424	cancer	Disease	MESH:D009369
17652946	1516	1524	GSK3beta	Gene	2932
17652946	1577	1585	GSK3beta	Gene	2932
17652946	1647	1653	cancer	Disease	MESH:D009369
17652946	1665	1704	non-insulin-dependent diabetes mellitus	Disease	MESH:D003924
17652946	1709	1728	Alzheimer's disease	Disease	MESH:D000544
17652946	Association	MESH:D013272	2932
17652946	Association	MESH:D005770	2932
17652946	Association	1499	2932
17652946	Negative_Correlation	MESH:C417521	MESH:D009369
17652946	Negative_Correlation	MESH:C479831	2932
17652946	Negative_Correlation	MESH:C479831	MESH:D009369
17652946	Association	MESH:D000544	2932
17652946	Association	MESH:D000255	1499
17652946	Association	MESH:D009369	2932
17652946	Negative_Correlation	MESH:C417521	2932
17652946	Association	MESH:D015179	2932
17652946	Association	MESH:D003924	2932

